6505--Norethindrone 5mg Tablet (VA-25-00005551)

Closed Solicitation Posted

This opportunity was awarded. See the award notice from .

Solicitation number
36E79724R0027
Agency
Responses due
Set-aside
No set-aside

Opportunity facts

Notice details come from SAM.gov. Updated .

About this opportunity

This solicitation is for the procurement of Norethindrone 5mg Tablets by the Department of Veterans Affairs National Acquisition Center. The purpose is to establish a supply source for the VA, DoD, Indian Health Service, Bureau of Prisons, and other federal agencies to purchase the drug through their respective Pharmaceutical Prime Vendor (PPV) programs. The contract will be effective for 1 year with four 1-year option periods. Offerors must include prices for the base year and all option years, provide a unique 11-digit NDC number, and meet FDA cGMP requirements. Awarded prices shall not exceed the Federal Ceiling Price, if applicable, plus a 0.5% Cost Recovery Fee. Subcontracting plan requirements and past performance reporting are also detailed. One award will be made for the Norethindrone 5mg Tablet line item.

This opportunity is not set aside and there is no indication of any potential incumbents or current contractors. The estimated total annual requirement across all participating agencies is provided, but no specific award values or budget ranges are disclosed. The place of performance is not specified.

Notice text

3 versions

Update #3 · Latest ·

RFP 36E79724R0027

Amendment A0002

This Amendment is hereby issued to delete the following:

Delete on Page 2 of RFP in its entirety:

Line item 1 is Unit of Use. All unit-of-use packaging identified in the Schedule of Supplies (i.e., 50s) shall contain a safety-cap capable of having the outer part of the cap deshelled and/or a convertible cap to produce a non-safety cap and a bottle with a minimum required size of 120cc volume. The safety cap must not exceed the diameter of the bottle. The bottle must have a cylindrical body and minimum of 5.75 circumference. The bottle must fit a label with a dimension of 5.25 x 2 . The 0.5 additional space is required to keep the bar code exposed and/or allow for the display of the expiration date and lot number.

Delete on Page 10, 5. PACKAGING REQUIREMENTS of RFP in its entirety:

Unit of Use Bottle Size All unit of use packaging identified in the Schedule of Supplies, (i.e., 50s), shall contain a safety-cap capable of having the outer part of the cap deshelled and / or a convertible cap to produce a non-safety cap and a bottle with a minimum required size of 120cc volume. The safety cap must not exceed the diameter of the bottle. The bottle must have a cylindrical body and minimum of 5.75 circumference. The bottle must fit a label with a dimension of 5.25 x 2 . The 0.5 additional space is required to keep the bar code exposed and/or allow for the display of the expiration date and lot number.

This Amendment is hereby issued to extend the offer due date under Request for Proposal (RFP) 36E79724R0027 for Norethindrone Acetate Tablet to November 15, 2024, 2:30 PM Central Standard Time.

Please submit all solicitation responses to adrienne.albachiara@va.gov AND diana.martinez1@va.gov.

Update #2 ·

Extension of offer due date to October 15, 2024.

Update #1 ·

N/A

Files

File Type Posted
36E79724R0027 0002.docx DOCX document
36E79724R0027 0001.docx DOCX document
36E79724R0027.docx DOCX document

Notice history

Notice Type Posted
6505--Norethindrone 5mg Tablet (VA-25-00005551) Award Award Notice
This notice Latest solicitation Solicitation
6505--Norethindrone 5mg Tablet (VA-25-00005551) Original Pre-Solicitation

Similar open opportunities

Opportunity Agency Set-aside Responses due
6505--Imatinib Tablets NAICS 325412 National Acquisition Center No set-aside

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity

GovTribe for Federal Contractors